MALDALENA CHAVIS: Open Payments
NPI 1487905014 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 10 payments from 7 companies in 2025. Trend: 2023 $59 · 2024 $84 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $80 |
| Braeburn Inc. | 2 | $46 |
| Indivior Inc. | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: INVEGA SUSTENNA, BRIXADI, SUBLOCADE, SHINGRIX.
Industry payments across PA — which companies pay providers there.
